Scientific Abstracts 1223 damage. However, it is not yet well known whether hyperuricemia is independently associated with renal involvement even in patients without known predisposing factors for hyperuricemia such as decreased renal function, old age, male gender, menopause, and drugs. Objectives: The aim of this study was to evaluate the association of baseline serum uric acid level and development of nephritis in patients diagnosed with SLE. Methods: We retrospectively reviewed electronic medical records of 101 female SLE patients whose ages at the time of diagnosis (baseline) were 45 years old or below in a tertiary medical center from January 2000 to March 2015. SLE with renal involvement was diagnosed when patients met the renal disorder of the 1997 ACR criteria for SLE. We compared baseline serum uric acid levels of the SLE patients who had nephritis at the time of diagnosis or later (nephritis group) with the patients who had not developed nephritis (non-nephritis group) during follow-up period. Results: Among 101 patients, 22 (22%) had hyperuricemia (serum uric acid ≥6 mg/dL) at baseline and 45 (45%) had developed nephritis during follow-up period (median 6.1 years). There were significant differences in baseline serum uric acid level, glomerular filtration rate (GFR), anti-dsDNA antibody and complement level between non-nephritis group and nephritis group (Table) . Interestingly, among 59 patients with normal renal function (baseline GFR ≥90 mL/min/1.73m
Oxidative damage to nucleic acids has been found to be associated with etiopathogenesis and disease activity of inflammatory disorders. Oxidised guanine species have been recognized as a biomarker of oxidative DNA and RNA damage by endogenously generated oxygen radicals. Sjögren's syndrome (SS) is an autoimmune disorder and associated with overexpression of proinflammatory cytokines. Related to excess expression of proinflammatory cytokines, a prooxidant state could be postulated in SS. Objectives: We aimed to evaluate levels of nucleic acids oxidative stress products in patients with SS. Methods: 11 patients with SS diagnosed according to 2012 American College of Rheumatology (ACR) Classification Criteria for Sjögren's Syndrome, 19 patients with psoriatic arthritis (PsA), diagnosed according to Classification Criteria for Psoriatic Arthritis (PSARC), 9 patients with rheumatoid arthritis (RA), diagnosed according to 2010 Rheumatoid Arthritis Classification Criteria, and 12 healthy controls were included. All SS patients were on hydroxychloroquine sulphate 400mg/day. All PsA and RA patients were on methotrexate 15-20mg/week and folic acid 5 mg/week. The serum samples were collected from participants and stored at -30 C until assayed. Three oxidised guanine species, 8-hydroxy-2'-deoxyguanosine as a DNA oxidation marker, 8-hydroxyguanosine as a RNA oxidation marker, and 8-hydroxyguanine as a DNA and RNA oxidation marker, were measured using DNA/RNA Oxidative Damage ELISA Kit (Cayman Chemicals, USA). Statistics: All data are presented as mean and standard deviation (SD). Differences between groups were examined using Kruskal-Wallis tests. The Mann-Whitney U test was performed to test the significance of pairwise differences using Bonferroni correction to adjust for multiple comparisons. A p-value less than 0.05 were considered as statistically significant. Statistical analysis of correlation was performed by using the Spearman rank test. Results: There was no statistically significant difference between the groups in terms of age and gender. The average level of serum oxidised guanine species in the PsA, RA, SS and healthy control groups were 2871.77±336.20, 2672.20±292.04, 3375.57±344.21, 2777.55±237.05 pg/mL respectively. Oxidised guanine species levels were significantly higher in patients with SS and positively correlated with CRP levels (p:0.011, r: 0.726) (table 2).
Conclusions:
A marked increase in DNA damage leading to oxidative stress may contribute to tissue damage in SS. Disclosure of Interest: None declared DOI: 10.1136/annrheumdis-2017-eular.3286 
